At a molecular level, Ahmed et al. [40] reported that RBO treatment overwhelmed the elevated hepatic de novo lipogenesis of the insulin resistance rats via downregulation of lipogenic genes, i.e., superoxide dismutase and catalase. This evidence concerns the gene CAT and Insulin resistance.